home / stock / swkh / swkh news

SWKH News and Press, SWK Holdings Corporation From 05/04/20

Stock Information
Company Name: SWK Holdings Corporation
Stock Symbol: SWKH
Market: OTC
Website: swkhold.com
Menu
SWKH SWKH Quote SWKH Short SWKH News SWKH Articles SWKH Message Board
Get SWKH Alerts

News, Short Squeeze, Breakout and More Instantly...
SWKH - Enteris BioPharma Appoints Rajiv Khosla, Ph.D., as Chief Executive Officer

BOONTON, N.J. , May 4, 2020 /PRNewswire/ --  Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), today announced the hiring o...
SWKH - SWK Holdings Corporation (SWKH) CEO Winston Black on Q4 2019 Results - Earnings Call Transcript

SWK Holdings Corporation (SWKH) Q4 2019 Earnings Conference Call March 31, 2020 10:00 AM ET Company Participants Jason Rando - Tiberend Strategic Advisors, Inc. Winston Black - Chairman and Chief Executive Officer Conference Call Participants Presentation Operator Goo...

SWKH - SWK Holdings Corporation Announces Financial Results for Fourth Quarter and Full-Year 2019

DALLAS , March 30, 2020 /PRNewswire/ -- Corporate Highlights Core specialty finance segment generated a 12.6% adjusted ROIC and yielding assets increased 4.8% year over year to $175.1 million Closed Enteris Biopharma acquisition SWK Holdings common stock uplisted to Nasdaq C...

SWKH - SWK Holdings Corporation Announces Reauthorization of Share Repurchase Program and Provides Business Update on Coronavirus (COVID-19) Impact

DALLAS , March 26, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small and mid-sized commercial-stage companies, today announced its preliminary revenue and non-GAAP adjusted net income for the fourth quart...
SWKH - SWK Holdings Provides Portfolio Update Highlighting Recent Achievements

DALLAS , Feb. 28, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today provided an update on the progress and achievements of its partner companies during the...

SWKH - Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer

BOONTON, N.J. , Feb. 10, 2020 /PRNewswire/ --  Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), today announced the hiring...

SWKH - Enteris BioPharma Receives 2019 Best of Boonton Award

BOONTON, N.J. , Jan. 27, 2020 /PRNewswire/ --  Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), announced that it has rece...
SWKH - SWK Holdings Corporation Announces Commencement of Trading on the Nasdaq Capital Market

DALLAS , Jan. 23, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its shares of common stock will begin trading on the Nasdaq Capital Market beginning today at 9:30 a.m., EST under the ticker symbo...

SWKH - SWK Holdings Corporation Announces Uplisting to Nasdaq Capital Market

DALLAS , Jan. 21, 2020 /PRNewswire/ -- SWK Holdings Corporation (SWKH.OB) ("SWK" or the "Company"), a life science focused specialty finance company, today announced that its shares of common stock have been approved for listing on the Nasdaq Capital Market. Trading on the exchange i...

SWKH - Enteris BioPharma's Licensing Partner, Cara Therapeutics, Announces Top Line Data from Phase 2 Trial of Peptelligence®-Engineered Oral KORSUVA(TM) for the Treatment of Pruritus in Patients with Advanced Chronic Kidney Disease (CKD)

BOONTON, N.J. , Dec. 6, 2019 /PRNewswire/ --  Enteris BioPharma, Inc. , a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned subsidiary of SWK Holdings Corporation (SWKH.OB), congratulates Cara Therapeutics ...
Previous 10 Next 10